Gsk Share Discussion Threads

[montyhedge] 11/1/2018 09:32

Dividend paid today, ahhh wanted these back below 1300p only for selfish reasons to reinvest the dividend and get more shares.

[philanderer] 10/1/2018 20:17

'The first female big pharma CEO had the perfect response to a question about women in leadership'

[montyhedge] 10/1/2018 15:20

I was most impressed with Emma at the Pharma conference San Francisco, she knows what she wants for the direction of GSK. Dividend safe no problem, US tax cuts helps profits as well.

But keep this price down for tomorrow at least, lol.

[abdullla] 10/1/2018 14:31

What an embarrassment,GSK the top pharma with wobbly knees,an share price cure drug is needed!

[montyhedge] 10/1/2018 14:29

Just want this shareprice down tomorrow reinvest my dividend from GSK.

[tradermichael] 10/1/2018 13:46

Well, what was that 1360+ about recently?

[dr biotech] 10/1/2018 12:47

I haven’t seen the interview but if she as asked about Pfizer’s there is no great answer. If she says not interested when there could be a bargain it wouldn’t look good and to show interest threatens the dividend. I’m not wholly sure the weakness seen since the Interview is down to her.

GSK is in my top 3, so it better be good this year😄

[abdullla] 10/1/2018 11:16

Hedgehogs are looking to short any stock that has some news circulating,they can easily manipulate good news into bad news to their advantage,so shutum is bestum !

[wormhasturned] 10/1/2018 11:03

Mind you,that closed the gap from last week!

[wormhasturned] 10/1/2018 11:02

Every time Emma Walmsley opens her pretty mouth this stock tanks, off course she is doing her job to enlighten investors, but it seems to be received in a very contrarian manner!😡

[tradermichael] 10/1/2018 09:06

Agree, andy.

Also, any sale of Pfizer consumer products would be at a premium and I suggest it would not be bought by a pharma company (like GSK), rather than by a company looking to expand its existing footprint and revenues in consumer healthcare (e.g. J&J) where this is already its core business.

[andycapp1] 10/1/2018 08:52

I suggest she just ought to keep quiet about acquitions. 85% or so of acquisitions destroy shareholder value so naturally Glaxo shareholders will be nervous! So Emma dahling pse keep shtum until you actually have something to say!!

[riskvsreward] 10/1/2018 07:07

Re Pfizer healthcare assets, a good outcome for gsk is either gsk buys them cheaply or a competitor buys them dearly.

[romeike] 10/1/2018 00:11

I don't think that quote or headline gives a fair assessment of what she actually said. She said it would be 'wierd' if they didn't look at it. She said 'if' they were to do something they wouldn't be prepared to overpay. She also said pharma was priority one, not consumer and that they 'didn't need' the Pfizer assets.

I imagine Pfizer will want too much for their assets so I can't see anything happening unless GSK perhaps buys a selection of the brands that best complement GSK.

Also, if she really was interested the worst thing she could do right now is announce that publicly unless she already has a 'bargain deal' agreed with them.

[fangorn2] 09/1/2018 21:39

montyhedge9 Jan '18 - 12:51 - 16195 of 16208


1 in 3 will get Shingles I was surprised myself. No wonder its a blockbuster.



Sorry Monty, didn't realise you were living in USA.

"Almost 1 out of every 3 people in the United States will develop shingles, also known as herpes zoster, in their lifetime." as per your link.

Whereas back here in UK, which is where most of us are living, according to NHS Wales, it is 1 in 4! As per my quote.

[fangorn2] 09/1/2018 21:36

Whoops, Emma's opened her mouth again...

"GSK may be interested in Pfizers consumer products unit at right price"

GlaxoSmithKline (GSK -1.2%) CEO Emma Walmsley said her firm would "have a look" at Pfizer's (PFE -0.1%) consumer products business but "would not overpay" for the asset.
Pfizer's consumer unit, which generated $3.4B in sales in 2016, could fetch as much as $15B.




At JPmorgan 20189 conference

[philanderer] 09/1/2018 20:34

GlaxoSmithKline CEO reshuffles 40% of management team in bid to bring in new ideas

[bracke] 09/1/2018 17:40

Good day Penycae

I know! I know! but I can't help myself. I'm attending CA. They say it will be a long job but they will eventually convert me to other methods which I find to painful to mention. Every now and again I slip back and have to put lines on charts.

I trust life is treating you and yours reasonably. Will this year be the year the bubble breaks? Probably not given that there is a genius in the White House.

Regards to monkey and don't let him eat too many bananas.

[penycae] 09/1/2018 17:25

Come on now bracke, you know all this charty stuff is of no relevance. Remember we just used to wait for a shower of herrings to arrive on the front lawn?
Always worked for BP!
Have a great New Year.
P.S The monkey send his regards.........

[bracke] 09/1/2018 16:23

I would normally have deleted the green lines as they no longer apply but left them in to give a better understanding of price action.

The black lines are a Pitchfork. If the middle black fails to support next in line is the upper brown line.

The pink and brown line shows the build up prior to the breakout.

[darias] 09/1/2018 16:13

Thats a lot of lines

[bracke] 09/1/2018 14:50

GSK HOURLY

[woodhawk] 09/1/2018 14:25

Actually, Fizzy, my timing with GVC has been a bit off lately. Nevertheless, doing well here, as usual with GSK, ditto BAB and PFC. Added MCRO to the list of recovery situations today.